DKSH Ups Asian Distribution Services; Sanofi Invests In-House in Africa
DKSH has upgraded its cold chain infrastructure in Southeast Asia as both small and large manufacturers increase their access needs to emerging markets.
DKSH has upgraded its cold chain infrastructure in Southeast Asia as both small and large manufacturers increase their access needs to emerging markets.
The EMA’s upgrade to the EudraGMDP database aims to increase the safety of the EU supply chain by releasing GMP certificates and other data so companies can ensure supplier compliance.
Despite offers from Amgen and Novartis reportedly worth up to $2bn, Hikma announced last week it will keep its profitable and growing injectable business.
Despite a downturn in the number of clinical trials across all phases, CROs may still see a substantial increase in bookings as large pharma and biotech companies look to keep costs down, according to an analyst.
The inventor of a reagent recently found to be highly explosive says many drug production chemicals may have similar profiles and that knowing how to handle them is the key.
Cytovance Biologics is once again expanding its manufacturing capabilities as CMOs compete to keep up with pharma’s growth rate in biologics.
The Kansas Bioscience Authority has awarded a $400,000 grant to the CRO PRA to create a new program to attract recent college graduates into the clinical research and CRO industries.